Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
2.160
-0.170 (-7.30%)
At close: Jan 30, 2026, 4:00 PM EST
2.150
-0.010 (-0.46%)
After-hours: Jan 30, 2026, 7:24 PM EST
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $261.08 million as of January 30, 2026. Its market cap has increased by 57.37% in one year.
Market Cap
261.08M
Enterprise Value
123.74M
1-Year Change
57.37%
Ranking
Category
Stock Price
$2.16
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $261.08M, a decrease of -35.41%. That is a compound annual growth rate of -3.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 281.60M | 64.10% |
| Dec 31, 2025 | 171.60M | 7.92% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
| Nov 6, 2014 | 404.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 279.73M |
| Cellectis | 279.26M |
| Abeona Therapeutics | 275.83M |
| Neurogene | 273.55M |
| OmniAb | 262.00M |
| Relmada Therapeutics | 260.33M |
| Fennec Pharmaceuticals | 259.23M |
| Cabaletta Bio | 247.40M |